Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
about
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical applicationRelaxation effects of clustered particles.Imaging liver metastases: current limitations and future prospects.Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions.Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners.Imaging of liver metastases: MRI.Role of preoperative local and distant staging in rectal cancer.Surgical therapy for colorectal metastases to the liver.Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.Staging cancer of the pancreasSurgical management of disappearing colorectal liver metastases.MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT.Tumour cell labelling by magnetic nanoparticles with determination of intracellular iron content and spatial distribution of the intracellular iron.Rapid and efficient cell labeling with a MRI contrast agent by electroporation in the presence of protamine sulfate.Rectal imaging and cancer.Intraoperative monitoring and postoperative imaging of hepatic cryosurgery.MRI of the liver.Patient selection for hepatic resection for metastatic colorectal cancerMagnetic retraction of bowel by intraluminal injectable cyanoacrylate-based magnetic glue.Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography.Modern surgery for liver metastases.Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases.Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions.Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CTFocal nodular hyperplasia: Intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging
P2860
Q24613744-6B36130B-B144-4330-9D5B-C48543F9276CQ30685691-802B7590-CB10-4102-8ACE-FDE34FAF9A28Q33921817-8DADE04B-7B51-41E1-973B-F53D96826205Q34391672-C244F32B-AAC3-49BE-89E8-B060F6AE09D3Q35897368-F8270799-4C58-41D3-AD74-26D5F39567ECQ36733410-A1BD869A-0330-4C03-8134-95C01D5C18E1Q36753224-91AB90A3-61B5-48EC-A5A7-87CBCC565DEDQ36832322-392B7228-9596-4137-A80F-4CB4317B4521Q37231625-32A04092-7DBD-4087-A052-14F1D01DAF0DQ37231657-E8883823-B412-4615-8085-992C82C83787Q37270092-4F4E5027-B220-40D1-9F9D-BCF90D1AFE69Q37794484-B172C572-CE61-4E06-B9CD-C93B67723B3DQ38137770-1B24CC52-086B-4665-AB3C-95D3DB3770DAQ38172159-D76FA136-0FCB-4A39-B0A0-A4446C00DA2BQ39159310-74B3C22B-2818-4012-8FE8-45155CA452B7Q39866576-8283C66F-F7E9-46F4-B73D-C5DA110A13D5Q40843962-2E01BC1D-2C6A-4033-BE36-CC452E5AF3FBQ41716629-463DD89A-08E4-4B47-B5B1-6164589FD34CQ41751278-4E143366-5D16-431A-BEBA-CD7332156E57Q41904824-ED3B07F2-843F-4E99-A5ED-A9EE0F3214B4Q42043926-2842475D-2A8C-4CD8-B164-2E3BCE6A6E6AQ42605317-C6B5108B-EED0-4900-832A-0A85373898ECQ42971220-D0FD71C0-E9A6-4913-A412-745276375943Q45076926-230A5DEB-8E5C-48DC-A9BA-026C72080FB9Q46364711-2C58AFD8-C2BB-4497-855E-2F132F45CFB0Q53170580-AA7BD7EB-F3D3-49AC-9B7C-D668C86FAEFDQ53307405-FB8EDD3E-ECB3-4243-92A2-0E42A5E20DBBQ53496562-84283C6A-8C23-44C9-AD35-33D1F4E4E597Q56989774-6223C331-C4CE-4102-8F54-41B79797036BQ57944355-C35F7A65-B09C-419E-AD53-79C605EFF1CD
P2860
Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
@en
type
label
Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
@en
prefLabel
Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
@en
P2093
P1433
P1476
Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
@en
P2093
A G van den Heuvel
I H Borel Rinkes
P A Wielopolski
P I Schmitz
P304
P356
10.1148/RADIOLOGY.203.2.9114103
P407
P577
1997-05-01T00:00:00Z